"info@hli.ubc.ca"

During the past decade, Centre for Heart Lung Innovation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Heart Lung Innovation" #1 collaborator was "Natural Sciences and Engineering Research Council, Canada" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Heart Lung Innovation" are "Breathing Exercises" (1 trials), "Familial Chylomicronemia Syndrome" (1 trials) and "Respiratory Muscles" (1 trials). Many other conditions were trialed in "Centre for Heart Lung Innovation" in a lesser frequency.

Most popular intervention types in "Centre for Heart Lung Innovation" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Inspiratory Muscle Training" (1 trials), "Olezarsen" (1 trials) and "Sham Inspiratory Muscle Training" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Heart Lung Innovation" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre for Heart Lung Innovation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre for Heart Lung Innovation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Heart Lung Innovation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".